RO4998452

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RO4998452, covering 2016-11-02 to 2020-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus [Phase 2]